# MIRABEGRON
> **ANDA209488** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-09-29
## Drug
- **FDA Application Number:** ANDA209488
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MIRABEGRON
- **Generic name:** MIRABEGRON
- **Active ingredients:** MIRABEGRON
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS PHARMS
- **Manufacturer:** Zydus Pharmaceuticals (USA) Inc.
- **First approval:** 2022-09-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209488)
---
*MORVS · CC0 1.0*